Get Real Time Here
| Day Range2.680 - 2.800 | 52 Wk Range2.350 - 8.180 | Open / Close2.780 / - | Float / Outstanding18.241M / 31.827M |
| Vol / Avg.15.924K / 66.137K | Mkt Cap88.151M | P/E- | 50d Avg. Price3.090 |
| Div / Yield (Forward)- / -% | Payout Ratio- | Total Float18.241M | EPS-2.520 |
Lyra Therapeutics Stock (NASDAQ:LYRA), Quotes and News Summary
Lyra Therapeutics Stock (NASDAQ: LYRA) stock price, news, charts, stock research, profile.
| Day Range2.680 - 2.800 | 52 Wk Range2.350 - 8.180 | Open / Close2.780 / - | Float / Outstanding18.241M / 31.827M |
| Vol / Avg.15.924K / 66.137K | Mkt Cap88.151M | P/E- | 50d Avg. Price3.090 |
| Div / Yield (Forward)- / -% | Payout Ratio- | Total Float18.241M | EPS-2.520 |
Earnings
see more| Q4 2022 | Est. | Actual | Surprise | ||||
|---|---|---|---|---|---|---|---|
| EPS | (EXPECTED)2023-03-08 | ||||||
| REV | |||||||
| Q3 2022 | Est. | Actual | Surprise | ||||
|---|---|---|---|---|---|---|---|
| EPS | -0.440 | -0.400 | 0.0400 | ||||
| REV | 140.000K | 359.000K | 219.000K |
Analyst Ratings
see more| Date | Analyst Firm | Analyst Name | Action | Rating | Action Price | Prior Price | Target |
|---|
How do I buy Lyra Therapeutics (LYRA) stock?
You can purchase shares of Lyra Therapeutics (NASDAQ: LYRA) through any online brokerage.
Who are Lyra Therapeutics's (LYRA) competitors?
Other companies in Lyra Therapeutics’s space includes: Opiant Pharma (NASDAQ:OPNT), SCYNEXIS (NASDAQ:SCYX), Ocuphire Pharma (NASDAQ:OCUP), Longboard Pharmaceuticals (NASDAQ:LBPH) and Qilian Intl Hldg Gr (NASDAQ:QLI).
What is the target price for Lyra Therapeutics (LYRA) stock?
The latest price target for Lyra Therapeutics (NASDAQ: LYRA) was reported by Cantor Fitzgerald on Tuesday, May 24, 2022. The analyst firm set a price target for 15.00 expecting LYRA to rise to within 12 months (a possible 441.57% upside). 1 analyst firms have reported ratings in the last year.
Current Stock Price for Lyra Therapeutics (LYRA)?
The stock price for Lyra Therapeutics (NASDAQ: LYRA) is $2.7697 last updated Today at January 31, 2023 at 3:39 PM UTC.
Does Lyra Therapeutics (LYRA) pay a dividend?
There are no upcoming dividends for Lyra Therapeutics.
When is Lyra Therapeutics (NASDAQ:LYRA) reporting earnings?
Lyra Therapeutics’s Q4 earnings are confirmed for Wednesday, March 8, 2023.
Is Lyra Therapeutics (LYRA) going to split?
There is no upcoming split for Lyra Therapeutics.
What sector and industry does Lyra Therapeutics (LYRA) operate in?
Lyra Therapeutics is in the Health Care sector and Pharmaceuticals industry. They are listed on the NASDAQ.
Lyra Therapeutics Stock (NASDAQ:LYRA), Quotes and News Summary
Lyra Therapeutics Stock (NASDAQ: LYRA) stock price, news, charts, stock research, profile.
| Day Range2.680 - 2.800 | 52 Wk Range2.350 - 8.180 | Open / Close2.780 / - | Float / Outstanding18.241M / 31.827M |
| Vol / Avg.15.924K / 66.137K | Mkt Cap88.151M | P/E- | 50d Avg. Price3.090 |
| Div / Yield (Forward)- / -% | Payout Ratio- | Total Float18.241M | EPS-2.520 |
Earnings
see more| Q4 2022 | Est. | Actual | Surprise | ||||
|---|---|---|---|---|---|---|---|
| EPS | (EXPECTED)2023-03-08 | ||||||
| REV | |||||||
| Q3 2022 | Est. | Actual | Surprise | ||||
|---|---|---|---|---|---|---|---|
| EPS | -0.440 | -0.400 | 0.0400 | ||||
| REV | 140.000K | 359.000K | 219.000K |
Analyst Ratings
see more| Date | Analyst Firm | Analyst Name | Action | Rating | Action Price | Prior Price | Target |
|---|
How do I buy Lyra Therapeutics (LYRA) stock?
You can purchase shares of Lyra Therapeutics (NASDAQ: LYRA) through any online brokerage.
Who are Lyra Therapeutics's (LYRA) competitors?
Other companies in Lyra Therapeutics’s space includes: Opiant Pharma (NASDAQ:OPNT), SCYNEXIS (NASDAQ:SCYX), Ocuphire Pharma (NASDAQ:OCUP), Longboard Pharmaceuticals (NASDAQ:LBPH) and Qilian Intl Hldg Gr (NASDAQ:QLI).
What is the target price for Lyra Therapeutics (LYRA) stock?
The latest price target for Lyra Therapeutics (NASDAQ: LYRA) was reported by Cantor Fitzgerald on Tuesday, May 24, 2022. The analyst firm set a price target for 15.00 expecting LYRA to rise to within 12 months (a possible 441.57% upside). 1 analyst firms have reported ratings in the last year.
Current Stock Price for Lyra Therapeutics (LYRA)?
The stock price for Lyra Therapeutics (NASDAQ: LYRA) is $2.7697 last updated Today at January 31, 2023 at 3:39 PM UTC.
Does Lyra Therapeutics (LYRA) pay a dividend?
There are no upcoming dividends for Lyra Therapeutics.
When is Lyra Therapeutics (NASDAQ:LYRA) reporting earnings?
Lyra Therapeutics’s Q4 earnings are confirmed for Wednesday, March 8, 2023.
Is Lyra Therapeutics (LYRA) going to split?
There is no upcoming split for Lyra Therapeutics.
What sector and industry does Lyra Therapeutics (LYRA) operate in?
Lyra Therapeutics is in the Health Care sector and Pharmaceuticals industry. They are listed on the NASDAQ.
Lyra Therapeutics Stock (NASDAQ:LYRA), Quotes and News Summary
Lyra Therapeutics Stock (NASDAQ: LYRA) stock price, news, charts, stock research, profile.
| Day Range2.680 - 2.800 | 52 Wk Range2.350 - 8.180 | Open / Close2.780 / - | Float / Outstanding18.241M / 31.827M |
| Vol / Avg.15.924K / 66.137K | Mkt Cap88.151M | P/E- | 50d Avg. Price3.090 |
| Div / Yield (Forward)- / -% | Payout Ratio- | Total Float18.241M | EPS-2.520 |
Earnings
see more| Q4 2022 | Est. | Actual | Surprise | ||||
|---|---|---|---|---|---|---|---|
| EPS | (EXPECTED)2023-03-08 | ||||||
| REV | |||||||
| Q3 2022 | Est. | Actual | Surprise | ||||
|---|---|---|---|---|---|---|---|
| EPS | -0.440 | -0.400 | 0.0400 | ||||
| REV | 140.000K | 359.000K | 219.000K |
Analyst Ratings
see more| Date | Analyst Firm | Analyst Name | Action | Rating | Action Price | Prior Price | Target |
|---|
How do I buy Lyra Therapeutics (LYRA) stock?
You can purchase shares of Lyra Therapeutics (NASDAQ: LYRA) through any online brokerage.
Who are Lyra Therapeutics's (LYRA) competitors?
Other companies in Lyra Therapeutics’s space includes: Opiant Pharma (NASDAQ:OPNT), SCYNEXIS (NASDAQ:SCYX), Ocuphire Pharma (NASDAQ:OCUP), Longboard Pharmaceuticals (NASDAQ:LBPH) and Qilian Intl Hldg Gr (NASDAQ:QLI).
What is the target price for Lyra Therapeutics (LYRA) stock?
The latest price target for Lyra Therapeutics (NASDAQ: LYRA) was reported by Cantor Fitzgerald on Tuesday, May 24, 2022. The analyst firm set a price target for 15.00 expecting LYRA to rise to within 12 months (a possible 441.57% upside). 1 analyst firms have reported ratings in the last year.
Current Stock Price for Lyra Therapeutics (LYRA)?
The stock price for Lyra Therapeutics (NASDAQ: LYRA) is $2.7697 last updated Today at January 31, 2023 at 3:39 PM UTC.
Does Lyra Therapeutics (LYRA) pay a dividend?
There are no upcoming dividends for Lyra Therapeutics.
When is Lyra Therapeutics (NASDAQ:LYRA) reporting earnings?
Lyra Therapeutics’s Q4 earnings are confirmed for Wednesday, March 8, 2023.
Is Lyra Therapeutics (LYRA) going to split?
There is no upcoming split for Lyra Therapeutics.
What sector and industry does Lyra Therapeutics (LYRA) operate in?
Lyra Therapeutics is in the Health Care sector and Pharmaceuticals industry. They are listed on the NASDAQ.
Lyra Therapeutics Stock (NASDAQ:LYRA), Quotes and News Summary
Lyra Therapeutics Stock (NASDAQ: LYRA) stock price, news, charts, stock research, profile.
| Day Range2.680 - 2.800 | 52 Wk Range2.350 - 8.180 | Open / Close2.780 / - | Float / Outstanding18.241M / 31.827M |
| Vol / Avg.15.924K / 66.137K | Mkt Cap88.151M | P/E- | 50d Avg. Price3.090 |
| Div / Yield (Forward)- / -% | Payout Ratio- | Total Float18.241M | EPS-2.520 |
Earnings
see more| Q4 2022 | Est. | Actual | Surprise | ||||
|---|---|---|---|---|---|---|---|
| EPS | (EXPECTED)2023-03-08 | ||||||
| REV | |||||||
| Q3 2022 | Est. | Actual | Surprise | ||||
|---|---|---|---|---|---|---|---|
| EPS | -0.440 | -0.400 | 0.0400 | ||||
| REV | 140.000K | 359.000K | 219.000K |
Analyst Ratings
see more| Date | Analyst Firm | Analyst Name | Action | Rating | Action Price | Prior Price | Target |
|---|
How do I buy Lyra Therapeutics (LYRA) stock?
You can purchase shares of Lyra Therapeutics (NASDAQ: LYRA) through any online brokerage.
Who are Lyra Therapeutics's (LYRA) competitors?
Other companies in Lyra Therapeutics’s space includes: Opiant Pharma (NASDAQ:OPNT), SCYNEXIS (NASDAQ:SCYX), Ocuphire Pharma (NASDAQ:OCUP), Longboard Pharmaceuticals (NASDAQ:LBPH) and Qilian Intl Hldg Gr (NASDAQ:QLI).
What is the target price for Lyra Therapeutics (LYRA) stock?
The latest price target for Lyra Therapeutics (NASDAQ: LYRA) was reported by Cantor Fitzgerald on Tuesday, May 24, 2022. The analyst firm set a price target for 15.00 expecting LYRA to rise to within 12 months (a possible 441.57% upside). 1 analyst firms have reported ratings in the last year.
Current Stock Price for Lyra Therapeutics (LYRA)?
The stock price for Lyra Therapeutics (NASDAQ: LYRA) is $2.7697 last updated Today at January 31, 2023 at 3:39 PM UTC.
Does Lyra Therapeutics (LYRA) pay a dividend?
There are no upcoming dividends for Lyra Therapeutics.
When is Lyra Therapeutics (NASDAQ:LYRA) reporting earnings?
Lyra Therapeutics’s Q4 earnings are confirmed for Wednesday, March 8, 2023.
Is Lyra Therapeutics (LYRA) going to split?
There is no upcoming split for Lyra Therapeutics.
What sector and industry does Lyra Therapeutics (LYRA) operate in?
Lyra Therapeutics is in the Health Care sector and Pharmaceuticals industry. They are listed on the NASDAQ.
Lyra Therapeutics Stock (NASDAQ:LYRA), Quotes and News Summary
Lyra Therapeutics Stock (NASDAQ: LYRA) stock price, news, charts, stock research, profile.
| Day Range2.680 - 2.800 | 52 Wk Range2.350 - 8.180 | Open / Close2.780 / - | Float / Outstanding18.241M / 31.827M |
| Vol / Avg.15.924K / 66.137K | Mkt Cap88.151M | P/E- | 50d Avg. Price3.090 |
| Div / Yield (Forward)- / -% | Payout Ratio- | Total Float18.241M | EPS-2.520 |
Earnings
see more| Q4 2022 | Est. | Actual | Surprise | ||||
|---|---|---|---|---|---|---|---|
| EPS | (EXPECTED)2023-03-08 | ||||||
| REV | |||||||
| Q3 2022 | Est. | Actual | Surprise | ||||
|---|---|---|---|---|---|---|---|
| EPS | -0.440 | -0.400 | 0.0400 | ||||
| REV | 140.000K | 359.000K | 219.000K |
Analyst Ratings
see more| Date | Analyst Firm | Analyst Name | Action | Rating | Action Price | Prior Price | Target |
|---|
How do I buy Lyra Therapeutics (LYRA) stock?
You can purchase shares of Lyra Therapeutics (NASDAQ: LYRA) through any online brokerage.
Who are Lyra Therapeutics's (LYRA) competitors?
Other companies in Lyra Therapeutics’s space includes: Opiant Pharma (NASDAQ:OPNT), SCYNEXIS (NASDAQ:SCYX), Ocuphire Pharma (NASDAQ:OCUP), Longboard Pharmaceuticals (NASDAQ:LBPH) and Qilian Intl Hldg Gr (NASDAQ:QLI).
What is the target price for Lyra Therapeutics (LYRA) stock?
The latest price target for Lyra Therapeutics (NASDAQ: LYRA) was reported by Cantor Fitzgerald on Tuesday, May 24, 2022. The analyst firm set a price target for 15.00 expecting LYRA to rise to within 12 months (a possible 441.57% upside). 1 analyst firms have reported ratings in the last year.
Current Stock Price for Lyra Therapeutics (LYRA)?
The stock price for Lyra Therapeutics (NASDAQ: LYRA) is $2.7697 last updated Today at January 31, 2023 at 3:39 PM UTC.
Does Lyra Therapeutics (LYRA) pay a dividend?
There are no upcoming dividends for Lyra Therapeutics.
When is Lyra Therapeutics (NASDAQ:LYRA) reporting earnings?
Lyra Therapeutics’s Q4 earnings are confirmed for Wednesday, March 8, 2023.
Is Lyra Therapeutics (LYRA) going to split?
There is no upcoming split for Lyra Therapeutics.
What sector and industry does Lyra Therapeutics (LYRA) operate in?
Lyra Therapeutics is in the Health Care sector and Pharmaceuticals industry. They are listed on the NASDAQ.
Lyra Therapeutics Stock (NASDAQ:LYRA), Quotes and News Summary
Lyra Therapeutics Stock (NASDAQ: LYRA) stock price, news, charts, stock research, profile.
| Day Range2.680 - 2.800 | 52 Wk Range2.350 - 8.180 | Open / Close2.780 / - | Float / Outstanding18.241M / 31.827M |
| Vol / Avg.15.924K / 66.137K | Mkt Cap88.151M | P/E- | 50d Avg. Price3.090 |
| Div / Yield (Forward)- / -% | Payout Ratio- | Total Float18.241M | EPS-2.520 |
Earnings
see more| Q4 2022 | Est. | Actual | Surprise | ||||
|---|---|---|---|---|---|---|---|
| EPS | (EXPECTED)2023-03-08 | ||||||
| REV | |||||||
| Q3 2022 | Est. | Actual | Surprise | ||||
|---|---|---|---|---|---|---|---|
| EPS | -0.440 | -0.400 | 0.0400 | ||||
| REV | 140.000K | 359.000K | 219.000K |
Analyst Ratings
see more| Date | Analyst Firm | Analyst Name | Action | Rating | Action Price | Prior Price | Target |
|---|
How do I buy Lyra Therapeutics (LYRA) stock?
You can purchase shares of Lyra Therapeutics (NASDAQ: LYRA) through any online brokerage.
Who are Lyra Therapeutics's (LYRA) competitors?
Other companies in Lyra Therapeutics’s space includes: Opiant Pharma (NASDAQ:OPNT), SCYNEXIS (NASDAQ:SCYX), Ocuphire Pharma (NASDAQ:OCUP), Longboard Pharmaceuticals (NASDAQ:LBPH) and Qilian Intl Hldg Gr (NASDAQ:QLI).
What is the target price for Lyra Therapeutics (LYRA) stock?
The latest price target for Lyra Therapeutics (NASDAQ: LYRA) was reported by Cantor Fitzgerald on Tuesday, May 24, 2022. The analyst firm set a price target for 15.00 expecting LYRA to rise to within 12 months (a possible 441.57% upside). 1 analyst firms have reported ratings in the last year.
Current Stock Price for Lyra Therapeutics (LYRA)?
The stock price for Lyra Therapeutics (NASDAQ: LYRA) is $2.7697 last updated Today at January 31, 2023 at 3:39 PM UTC.
Does Lyra Therapeutics (LYRA) pay a dividend?
There are no upcoming dividends for Lyra Therapeutics.
When is Lyra Therapeutics (NASDAQ:LYRA) reporting earnings?
Lyra Therapeutics’s Q4 earnings are confirmed for Wednesday, March 8, 2023.
Is Lyra Therapeutics (LYRA) going to split?
There is no upcoming split for Lyra Therapeutics.
What sector and industry does Lyra Therapeutics (LYRA) operate in?
Lyra Therapeutics is in the Health Care sector and Pharmaceuticals industry. They are listed on the NASDAQ.
Lyra Therapeutics Stock (NASDAQ:LYRA), Quotes and News Summary
Lyra Therapeutics Stock (NASDAQ: LYRA) stock price, news, charts, stock research, profile.
| Day Range2.680 - 2.800 | 52 Wk Range2.350 - 8.180 | Open / Close2.780 / - | Float / Outstanding18.241M / 31.827M |
| Vol / Avg.15.924K / 66.137K | Mkt Cap88.151M | P/E- | 50d Avg. Price3.090 |
| Div / Yield (Forward)- / -% | Payout Ratio- | Total Float18.241M | EPS-2.520 |
Earnings
see more| Q4 2022 | Est. | Actual | Surprise | ||||
|---|---|---|---|---|---|---|---|
| EPS | (EXPECTED)2023-03-08 | ||||||
| REV | |||||||
| Q3 2022 | Est. | Actual | Surprise | ||||
|---|---|---|---|---|---|---|---|
| EPS | -0.440 | -0.400 | 0.0400 | ||||
| REV | 140.000K | 359.000K | 219.000K |
Analyst Ratings
see more| Date | Analyst Firm | Analyst Name | Action | Rating | Action Price | Prior Price | Target |
|---|
How do I buy Lyra Therapeutics (LYRA) stock?
You can purchase shares of Lyra Therapeutics (NASDAQ: LYRA) through any online brokerage.
Who are Lyra Therapeutics's (LYRA) competitors?
Other companies in Lyra Therapeutics’s space includes: Opiant Pharma (NASDAQ:OPNT), SCYNEXIS (NASDAQ:SCYX), Ocuphire Pharma (NASDAQ:OCUP), Longboard Pharmaceuticals (NASDAQ:LBPH) and Qilian Intl Hldg Gr (NASDAQ:QLI).
What is the target price for Lyra Therapeutics (LYRA) stock?
The latest price target for Lyra Therapeutics (NASDAQ: LYRA) was reported by Cantor Fitzgerald on Tuesday, May 24, 2022. The analyst firm set a price target for 15.00 expecting LYRA to rise to within 12 months (a possible 441.57% upside). 1 analyst firms have reported ratings in the last year.
Current Stock Price for Lyra Therapeutics (LYRA)?
The stock price for Lyra Therapeutics (NASDAQ: LYRA) is $2.7697 last updated Today at January 31, 2023 at 3:39 PM UTC.
Does Lyra Therapeutics (LYRA) pay a dividend?
There are no upcoming dividends for Lyra Therapeutics.
When is Lyra Therapeutics (NASDAQ:LYRA) reporting earnings?
Lyra Therapeutics’s Q4 earnings are confirmed for Wednesday, March 8, 2023.
Is Lyra Therapeutics (LYRA) going to split?
There is no upcoming split for Lyra Therapeutics.
What sector and industry does Lyra Therapeutics (LYRA) operate in?
Lyra Therapeutics is in the Health Care sector and Pharmaceuticals industry. They are listed on the NASDAQ.
Lyra Therapeutics Stock (NASDAQ:LYRA), Quotes and News Summary
Lyra Therapeutics Stock (NASDAQ: LYRA) stock price, news, charts, stock research, profile.
| Day Range2.680 - 2.800 | 52 Wk Range2.350 - 8.180 | Open / Close2.780 / - | Float / Outstanding18.241M / 31.827M |
| Vol / Avg.15.924K / 66.137K | Mkt Cap88.151M | P/E- | 50d Avg. Price3.090 |
| Div / Yield (Forward)- / -% | Payout Ratio- | Total Float18.241M | EPS-2.520 |
Earnings
see more| Q4 2022 | Est. | Actual | Surprise | ||||
|---|---|---|---|---|---|---|---|
| EPS | (EXPECTED)2023-03-08 | ||||||
| REV | |||||||
| Q3 2022 | Est. | Actual | Surprise | ||||
|---|---|---|---|---|---|---|---|
| EPS | -0.440 | -0.400 | 0.0400 | ||||
| REV | 140.000K | 359.000K | 219.000K |
Analyst Ratings
see more| Date | Analyst Firm | Analyst Name | Action | Rating | Action Price | Prior Price | Target |
|---|
How do I buy Lyra Therapeutics (LYRA) stock?
You can purchase shares of Lyra Therapeutics (NASDAQ: LYRA) through any online brokerage.
Who are Lyra Therapeutics's (LYRA) competitors?
Other companies in Lyra Therapeutics’s space includes: Opiant Pharma (NASDAQ:OPNT), SCYNEXIS (NASDAQ:SCYX), Ocuphire Pharma (NASDAQ:OCUP), Longboard Pharmaceuticals (NASDAQ:LBPH) and Qilian Intl Hldg Gr (NASDAQ:QLI).
What is the target price for Lyra Therapeutics (LYRA) stock?
The latest price target for Lyra Therapeutics (NASDAQ: LYRA) was reported by Cantor Fitzgerald on Tuesday, May 24, 2022. The analyst firm set a price target for 15.00 expecting LYRA to rise to within 12 months (a possible 441.57% upside). 1 analyst firms have reported ratings in the last year.
Current Stock Price for Lyra Therapeutics (LYRA)?
The stock price for Lyra Therapeutics (NASDAQ: LYRA) is $2.7697 last updated Today at January 31, 2023 at 3:39 PM UTC.
Does Lyra Therapeutics (LYRA) pay a dividend?
There are no upcoming dividends for Lyra Therapeutics.
When is Lyra Therapeutics (NASDAQ:LYRA) reporting earnings?
Lyra Therapeutics’s Q4 earnings are confirmed for Wednesday, March 8, 2023.
Is Lyra Therapeutics (LYRA) going to split?
There is no upcoming split for Lyra Therapeutics.
What sector and industry does Lyra Therapeutics (LYRA) operate in?
Lyra Therapeutics is in the Health Care sector and Pharmaceuticals industry. They are listed on the NASDAQ.
Lyra Therapeutics Stock (NASDAQ:LYRA), Quotes and News Summary
Lyra Therapeutics Stock (NASDAQ: LYRA) stock price, news, charts, stock research, profile.
| Day Range2.680 - 2.800 | 52 Wk Range2.350 - 8.180 | Open / Close2.780 / - | Float / Outstanding18.241M / 31.827M |
| Vol / Avg.15.924K / 66.137K | Mkt Cap88.151M | P/E- | 50d Avg. Price3.090 |
| Div / Yield (Forward)- / -% | Payout Ratio- | Total Float18.241M | EPS-2.520 |
Earnings
see more| Q4 2022 | Est. | Actual | Surprise | ||||
|---|---|---|---|---|---|---|---|
| EPS | (EXPECTED)2023-03-08 | ||||||
| REV | |||||||
| Q3 2022 | Est. | Actual | Surprise | ||||
|---|---|---|---|---|---|---|---|
| EPS | -0.440 | -0.400 | 0.0400 | ||||
| REV | 140.000K | 359.000K | 219.000K |
Analyst Ratings
see more| Date | Analyst Firm | Analyst Name | Action | Rating | Action Price | Prior Price | Target |
|---|
How do I buy Lyra Therapeutics (LYRA) stock?
You can purchase shares of Lyra Therapeutics (NASDAQ: LYRA) through any online brokerage.
Who are Lyra Therapeutics's (LYRA) competitors?
Other companies in Lyra Therapeutics’s space includes: Opiant Pharma (NASDAQ:OPNT), SCYNEXIS (NASDAQ:SCYX), Ocuphire Pharma (NASDAQ:OCUP), Longboard Pharmaceuticals (NASDAQ:LBPH) and Qilian Intl Hldg Gr (NASDAQ:QLI).
What is the target price for Lyra Therapeutics (LYRA) stock?
The latest price target for Lyra Therapeutics (NASDAQ: LYRA) was reported by Cantor Fitzgerald on Tuesday, May 24, 2022. The analyst firm set a price target for 15.00 expecting LYRA to rise to within 12 months (a possible 441.57% upside). 1 analyst firms have reported ratings in the last year.
Current Stock Price for Lyra Therapeutics (LYRA)?
The stock price for Lyra Therapeutics (NASDAQ: LYRA) is $2.7697 last updated Today at January 31, 2023 at 3:39 PM UTC.
Does Lyra Therapeutics (LYRA) pay a dividend?
There are no upcoming dividends for Lyra Therapeutics.
When is Lyra Therapeutics (NASDAQ:LYRA) reporting earnings?
Lyra Therapeutics’s Q4 earnings are confirmed for Wednesday, March 8, 2023.
Is Lyra Therapeutics (LYRA) going to split?
There is no upcoming split for Lyra Therapeutics.
What sector and industry does Lyra Therapeutics (LYRA) operate in?
Lyra Therapeutics is in the Health Care sector and Pharmaceuticals industry. They are listed on the NASDAQ.